K Number
K071477
Device Name
REVERTO 55 AND 37 SHAPE MEMORY STAPLES
Date Cleared
2007-08-15

(78 days)

Product Code
Regulation Number
888.3030
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
reVERTO™ Shape Memory Staples are intended for use in: Fixation of Osteotomies of the Hand, Foot and Tibia Arthrodesis of the Joints of the Hand and Foot Fixation of Soft Tissue to Bone, as in the case of the Anterior Cruciate Ligament reVERTO™ Shape Memory Staples are also indicated for adjunctive fixation of Small Bone Fragments of: The Upper Extremity, such as the Radius, Ulna, Humerus, Clavicle and Scapula The Lower Extremity, such as the Tibia, Fibula and the Femur The Upper Torso, such as the Sternum and the Ribs
Device Description
reVERTO™ Shape Memory Staples are dynamic compression implants that use shape memory metal nickel-titanium alloy called NiTinol (see below for more information on NiTinol). The NiTinol construction causes the legs of the implant to deflect, thereby creating a compressive force across the site of fixation. reVERTO Shape Memory Staples are advantageous to screws and plates in that they require less disruption of the surrounding bone for implantation and provide a 'low-profile' fixation. The most important factor related to the use of NiTinol is its ability to maintain a compressive force across the site of fixation during the healing process.
More Information

Not Found

No
The device description focuses on the material properties (NiTinol) and mechanical function of the staples, with no mention of AI or ML.

No
The device, reVERTO™ Shape Memory Staples, is an implant used for fixation of osteotomies, arthrodesis, and soft tissue to bone, and for adjunctive fixation of small bone fragments. While it aids in the healing process by providing dynamic compression, its primary function is mechanical support and fixation rather than directly providing a therapeutic effect or treatment of a disease.

No

The reVERTO™ Shape Memory Staples are described as implants used for fixation in orthopedics, which is a therapeutic function, not a diagnostic one. They do not identify or analyze medical conditions.

No

The device description clearly states that the device is a physical implant made of nickel-titanium alloy (NiTinol), which is a hardware component.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body.
  • reVERTO™ Shape Memory Staples Function: The description clearly states that reVERTO™ Shape Memory Staples are implants used for fixation of bones and soft tissue within the body. They are a surgical device, not a diagnostic tool that analyzes samples.

The intended use and device description focus entirely on the mechanical function of the staples for surgical repair and stabilization, not on analyzing biological samples for diagnostic purposes.

N/A

Intended Use / Indications for Use

reVERTO™ Shape Memory Staples are intended for use in: Fixation of Osteotomies of the Hand, Foot and Tibia Arthrodesis of the Joints of the Hand and Foot Fixation of Soft Tissue to Bone, as in the case of the Anterior Cruciate Ligament reVERTO™ Shape Memory Staples are also indicated for adjunctive fixation of Small Bone Fragments of: The Upper Extremity, such as the Radius, Ulna, Humerus, Clavicle and Scapula The Lower Extremity, such as the Tibia, Fibula and the Femur The Upper Torso, such as the Sternum and the Ribs

Product codes

JDR

Device Description

reVERTOTM Shape Memory Staples are dynamic compression implants that use shape memory metal nickel-titanium alloy called NiTinol (see below for more information on NiTinol). The NiTinol construction causes the legs of the implant to deflect, thereby creating a compressive force across the site of fixation. reVERTO Shape Memory Staples are advantageous to screws and plates in that they require less disruption of the surrounding bone for implantation and provide a 'low-profile' fixation. The most important factor related to the use of NiTinol is its ability to maintain a compressive force across the site of fixation during the healing process.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Hand, Foot, Tibia, Joints of the Hand and Foot, Soft Tissue to Bone, Upper Extremity (Radius, Ulna, Humerus, Clavicle, Scapula), Lower Extremity (Tibia, Fibula, Femur), Upper Torso (Sternum, Ribs)

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K993714, K001354, K051408, K060014, K002695

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)

Not Found

§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.

(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.

0

510(K) SUMMARY

Subject 510(k) Number ________________________________________________________________________________________________________________________________________________________

Sponsor

Core Essence Orthopaedics, LLC 301 Oxford Valley Road Suite 905B Yardley, PA 19067

FDA Establishment Registration Number

Pending

Official Contact

Shawn T. Huxel, CEO & President Core Essence Orthopaedics, LLC 301 Oxford Valley Road Suite 905B Yardley, PA 19067 Phone - (215) 310-9534 Fax - (609) 482-4957 Mobile - (908) 896-5893

Proprietary Name

reVERTOTM Shape Memory Staples

Common Name

Staple, Fixation, Bone

Classification Name and Reference

Sec. 888.3030 Single/multiple component metallic bone fixation appliances and accessories

Regulatory Class

Class II

Device Product Code

(Panel 87) JDR

Date Prepared

24 May, 2007

Core Essence Orthopaedics, LLC

AUG 1 5 2007

1

Brief Description of Device

reVERTOTM Shape Memory Staples are dynamic compression implants that use shape memory metal nickel-titanium alloy called NiTinol (see below for more information on NiTinol). The NiTinol construction causes the legs of the implant to deflect, thereby creating a compressive force across the site of fixation. reVERTO Shape Memory Staples are advantageous to screws and plates in that they require less disruption of the surrounding bone for implantation and provide a 'low-profile' fixation. The most important factor related to the use of NiTinol is its ability to maintain a compressive force across the site of fixation during the healing process.

Indications for Use

reVERTO™ Shape Memory Staples are intended for use in:

Fixation of Osteotomies of the Hand, Foot and Tibia

Arthrodesis of the Joints of the Hand and Foot

Fixation of Soft Tissue to Bone, as in the case of the Anterior Cruciate Ligament

reVERTO™ Shape Memory Staples are also indicated for adjunctive fixation of Small Bone Fragments of:

The Upper Extremity, such as the Radius, Ulna, Humerus, Clavicle and Scapula

The Lower Extremity, such as the Tibia, Fibula and the Femur

The Upper Torso, such as the Sternum and the Ribs

Basis for Substantial Equivalence

The substantial equivalence of the reVERTO Shape Memory Staples is based on the equivalence in intended use, materials, operational principals, and indications to:

DEVICEManufacturerTrade Name
K993714Biomedical EnterprisesMemograph
K001354Biomedical EnterprisesOSStaple
K051408IntelifuseStimulink
K060014IntelifuseStimulink
K002695Telos MedicalMemodyn Staples

END OF 510(K) SUMMARY

Core Essence Orthopaedics, LLC

2

Public Health Service

Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

ood and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Core Essence Orthopaedics, LLC % Mr. Shawn T. Huxel CEO and President 301 Oxford Valley Rd. Suite 905B Yardlev. Pennsylvania 19067

AUG 15 2007

Re: K071477 Trade/Device Name: reVERTO™ 55 Shape Memory Staples and reVERTO™ 37 Shape Memory Staples Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple component metallic bone fixation appliances and accessorites

Regulatory Class: II Product Code: JDR Dated: July 17, 2007 Received: July 18, 2007

Dear Mr. Huxel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

3

Page 2 - Mr. Shawn T. Huxel

CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Sincerely yours,

Karlaue Buehup

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Indications for Use

510 (K) NUMBER IF KNOWN: DEVICE NAME: reVERTO™ Shape Memory Staples

Indications for Use:

reVERTO™ Shape Memory Staples are intended for use in:

Fixation of Osteotomies of the Hand, Foot and Tibia Arthrodesis of the Joints of the Hand and Foot

Fixation of Soft Tissue to Bone, as in the case of the Anterior Cruciate Ligament reVERTO™ Shape Memory Staples are also indicated for adjunctive fixation of Small Bone Fragments of:

The Upper Extremity, such as the Radius, Ulna, Humerus, Clavicle and Scapula The Lower Extremity, such as the Tibia, Fibula and the Femur The Upper Torso, such as the Sternum and the Ribs

Prescription Use W

AND/OR

(Part 21 CFR 801 Subpart D)

Over-the-Counter Use

(21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE, IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Yaulan Buehum for MOM

(Division Sign-Off) Division of General, Restorative, and Neurological Devices

Core Essence Orthopaedics, LLC

Confidential 510(k) Number_K071477 Page 57 of 60